SciHub
文献互助
期刊查询
一搜即达
科研导航
即时热点
交流社区
登录
注册
发布
文献
求助
首页
我的求助
捐赠本站
Xihu
Lv1
40 积分
2024-04-22 加入
最近求助
最近应助
互助留言
Development of Novel Indole-Based Covalent Inhibitors of TEAD as Potential Antiliver Cancer Agents
1个月前
已完结
Irreversible inhibition of epidermal growth factor receptor tyrosine kinase with In Vivo activity by N-[4-[(3-bromophenyl)amino]-6-quinazolinyl]-2-butynamide (CL-387,785)
1个月前
已关闭
Optimization of 6,7-Disubstituted-4-(arylamino)quinoline-3-carbonitriles as Orally Active, Irreversible Inhibitors of Human Epidermal Growth Factor Receptor-2 Kinase Activity
1个月前
已完结
Irreversible inhibitors of the erbB family of protein tyrosine kinases
1个月前
已关闭
Discovery of Zanubrutinib (BGB-3111), a Novel, Potent, and Selective Covalent Inhibitor of Bruton’s Tyrosine Kinase
1个月前
已完结
Tyrosine kinase inhibitors. 15. 4-(Phenylamino)quinazoline and 4-(phenylamino)pyrido[d]pyrimidine acrylamides as irreversible inhibitors of the ATP binding site of the epidermal growth factor receptor
1个月前
已完结
Discovery of Selective Irreversible Inhibitors for Bruton’s Tyrosine Kinase
1个月前
已完结
Characterization of ibrutinib as a non-covalent inhibitor of SRC-family kinases
1个月前
已完结
Clinical perspectives for irreversible tyrosine kinase inhibitors in cancer
1个月前
已完结
Noxious compounds activate TRPA1 ion channels through covalent modification of cysteines
1个月前
已完结
没有进行任何应助
无人上传【积分已退回】
1个月前
无人上传【积分已退回】
1个月前
最近帖子
最近评论
没有发布任何帖子
没有发布任何评论